Australia markets open in 9 hours 56 minutes

Third Harmonic Bio, Inc. (THRD)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
13.09+0.14 (+1.08%)
As of 10:03AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 530.30M
Enterprise value 271.24M
Trailing P/E 13.41
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)2.01
Enterprise value/revenue N/A
Enterprise value/EBITDA 4.25

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3159.00%
S&P500 52-week change 324.71%
52-week high 316.94
52-week low 34.72
50-day moving average 312.61
200-day moving average 39.50

Share statistics

Avg vol (3-month) 3135.85k
Avg vol (10-day) 371.71k
Shares outstanding 540.95M
Implied shares outstanding 640.95M
Float 89.68M
% held by insiders 19.95%
% held by institutions 192.70%
Shares short (15 May 2024) 41.06M
Short ratio (15 May 2024) 46.94
Short % of float (15 May 2024) 45.77%
Short % of shares outstanding (15 May 2024) 42.60%
Shares short (prior month 15 Apr 2024) 4806.21k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-9.62%
Return on equity (ttm)-10.84%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -43.21M
Net income avi to common (ttm)-29.59M
Diluted EPS (ttm)-0.75
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)262.83M
Total cash per share (mrq)6.42
Total debt (mrq)3.77M
Total debt/equity (mrq)1.43%
Current ratio (mrq)66.10
Book value per share (mrq)6.55

Cash flow statement

Operating cash flow (ttm)-20.04M
Levered free cash flow (ttm)-18.3M